Claudia Elera-Fitzcarrald, Graciela S Alarcón, Manuel F Ugarte-Gil
{"title":"Challenges in the care of patients with systemic lupus erythematous and lupus nephritis in Latin America.","authors":"Claudia Elera-Fitzcarrald, Graciela S Alarcón, Manuel F Ugarte-Gil","doi":"10.1080/14656566.2025.2464913","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Systemic lupus erythematosus is a rare disease; however, it is one of the leading causes of death in young women, in particular those with a larger percentage of Amerindian ancestry.</p><p><strong>Areas covered: </strong>This article provides a review of the epidemiology of systemic lupus erythematosus and lupus nephritis in the Latin American population, as well as the challenges for the appropriate management of these patients, including delay in diagnosis, healthcare access and access to new drugs in the region. We propose potential solutions for these problems, including activities to be done by the governments, healthcare systems and healthcare professionals.</p><p><strong>Expert opinion: </strong>Systemic lupus erythematosus, in particular lupus nephritis, is more severe in patients with a larger percentage of Amerindian ancestry; this is influenced not only by their ancestry but also by their sociodemographic characteristics, including access to healthcare and the availability of new drugs. Several strategies to improve diagnosis, management and access to medication need to be done to reduce these disparities.</p>","PeriodicalId":12184,"journal":{"name":"Expert Opinion on Pharmacotherapy","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14656566.2025.2464913","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Systemic lupus erythematosus is a rare disease; however, it is one of the leading causes of death in young women, in particular those with a larger percentage of Amerindian ancestry.
Areas covered: This article provides a review of the epidemiology of systemic lupus erythematosus and lupus nephritis in the Latin American population, as well as the challenges for the appropriate management of these patients, including delay in diagnosis, healthcare access and access to new drugs in the region. We propose potential solutions for these problems, including activities to be done by the governments, healthcare systems and healthcare professionals.
Expert opinion: Systemic lupus erythematosus, in particular lupus nephritis, is more severe in patients with a larger percentage of Amerindian ancestry; this is influenced not only by their ancestry but also by their sociodemographic characteristics, including access to healthcare and the availability of new drugs. Several strategies to improve diagnosis, management and access to medication need to be done to reduce these disparities.
期刊介绍:
Expert Opinion on Pharmacotherapy is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.